Pfizer Reports Second-Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Tanker struck by projectile in Strait of Hormuz
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- AppLovin shares fall after court denies request against Unity
Pfizer (PFE) Tops Q2 EPS by 12c, Raises FY Guidance
July 28, 2020 6:47 AM EDT(Updated - July 28, 2020 6:49 AM EDT)
Pfizer (NYSE: PFE) reported Q2 EPS of $0.78, $0.12 better than the analyst estimate of $0.66. Revenue for the quarter came in at $11.8 billion versus the consensus estimate of $11.55 billion.
GUIDANCE:
Pfizer sees 2020 EPS of $2.85-$2.95, versus the... More
